...
首页> 外文期刊>Journal of Biomolecular Structure and Dynamics >Design of antimalarial transmission blocking agents: Pharmacophore mapping of ligands active against stage-V mature gametocytes of Plasmodium falciparum
【24h】

Design of antimalarial transmission blocking agents: Pharmacophore mapping of ligands active against stage-V mature gametocytes of Plasmodium falciparum

机译:抗疟型传动阻断剂的设计:配体对疟原虫的阶段 - V成熟配体的配体的药物映射

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The discovery of transmission-blocking (T-B) agents is crucial for preventing and complete removal of malaria infection. However, most of the existing antimalarials are only active against the asexual stages of Plasmodium parasite, but ineffective against the sexual stage (gametocytes). In this background, we have developed pharmacophore models against the stage-V mature gametocytes of P. falciparum parasites. The pharmacophore model (Hypo-1) showed five pharmacophoric features namely, one hydrogen bond donor (HBD), one hydrophobic aliphatic (HYAl), one ring aromatic (RA), and two hydrophobic aromatic (HYAr) essential for the anti-gametocytic activity. The amino, methyl, fused phenyl ring of the quinazoline heterocycle, two phenyl rings of biphenyl moiety (HBD, HYAl, HYAr1, HYAr2 and RA) are the crucial features responsible for the non-specific anti-gametocytic activity (PfG). Subsequently, the model (Hypo-2) developed against the stage-V female gametocytes (PffG) showed the contribution of three pharmacophoric features namely, two hydrogen bond acceptor (HYA) and one RA required for the anti-gametocytic activity. The sulfhydryl, imine and pyridyl groups are observed to be essential for anti-gametocytic activity against female gametocytes. Both the models (PfG and PfGG) showed the classification accuracies of 78.26 and 71.64% for training set compounds and 60.80 and 60.18% for the test set compounds, respectively, for classification of compounds into higher and lower active classes. Also, both the models were found to retain the higher active compounds (IC50 <100 nM) in top 1% of total compounds (actives and decoys) as observed after screening the decoy set compounds. Communicated by Ramaswamy H Sarma
机译:传导阻断(T-B)试剂的发现对于预防和完全去除疟疾感染至关重要。然而,大多数现有的抗疟药仅针对寄生虫疟原虫的无性阶段,但对性阶段(Gametocytes)无效。在此背景下,我们开发了针对P. falciparum寄生虫的阶段-V成熟配子细胞的药物团模型。药效线模型(Hypo-1)显示了五种药物特征,即一个氢键供体(HBD),一种疏水性脂族(缘),一个环芳族(Ra)和两个疏水性芳族(RA),以及用于抗配子致氢活性的必由之限。氨基,甲基,熔融苯基环的喹唑啉杂环,两种苯基部分的苯环(HBD,遮蔽Hyal,Hyar1,Hyar2和Ra)是负责非特异性抗配子织物活性(PFG)的至关重要。随后,针对雌性游戏术(PFFG)开发的模型(Hypo-2)显示了三种药拍特征的贡献,即抗配子键活性所需的两个氢键受体(HYA)和一个RA。观察到巯基,亚胺和吡啶基,对雌性配子织物的抗配子细胞活性至关重要。模型(PFG和PFGG)均分别显示出培训组化合物的78.26和71.64%的分类精度,分别用于试验化合物的60.80.80和60.18%,用于将化合物分类为更高且较低的活性等级。此外,在筛选诱饵套合化合物之后观察到,发现两种模型都被发现将更高的活性化合物(IC50 <100nm)保持在总体化合物(活性物质和诱饵)的前1%。通过ramaswamy h sarma沟通

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号